196 related articles for article (PubMed ID: 37905148)
21. A retrospective study of venous thromboembolism in acute leukemia patients treated at the University of Texas MD Anderson Cancer Center.
Vu K; Luong NV; Hubbard J; Zalpour A; Faderl S; Thomas DA; Yang D; Kantarjian H; Kroll MH
Cancer Med; 2015 Jan; 4(1):27-35. PubMed ID: 25487644
[TBL] [Abstract][Full Text] [Related]
22. Influence of cytokines on early death and coagulopathy in newly diagnosed patients with acute promyelocytic leukemia.
Zhao S; Ge Y; Li Z; Yang T
Front Immunol; 2023; 14():1100151. PubMed ID: 37063881
[TBL] [Abstract][Full Text] [Related]
23. Prospective study of fibrinolytic markers and venous thromboembolism.
Folsom AR; Cushman M; Heckbert SR; Rosamond WD; Aleksic N
J Clin Epidemiol; 2003 Jun; 56(6):598-603. PubMed ID: 12873656
[TBL] [Abstract][Full Text] [Related]
24. Incidence of Upper Extremity Deep Vein Thrombosis in Acute Leukemia and Effect on Mortality.
Poh C; Brunson A; Keegan T; Wun T; Mahajan A
TH Open; 2020 Oct; 4(4):e309-e317. PubMed ID: 33134806
[TBL] [Abstract][Full Text] [Related]
25. Treatment of venous thromboembolism in acute leukemia: A systematic review.
Ahrari A; Al-Ani F; Wang YP; Lazo-Langner A
Thromb Res; 2019 Jun; 178():1-6. PubMed ID: 30921533
[TBL] [Abstract][Full Text] [Related]
26. Management of Disseminated Intravascular Coagulation in Acute Leukemias.
Ten Cate H; Leader A
Hamostaseologie; 2021 Apr; 41(2):120-126. PubMed ID: 33860520
[TBL] [Abstract][Full Text] [Related]
27. Effects of all-trans-retinoic acid and arsenic trioxide on the hemostatic disturbance associated with acute promyelocytic leukemia.
Zhao W; Wang H; Wang X; Wu F; Guo W; Qu B; Shen Z; Wang Z
Thromb Res; 2001 May; 102(3):197-204. PubMed ID: 11369412
[TBL] [Abstract][Full Text] [Related]
28. Tissue factor-bearing microparticles are a link between acute promyelocytic leukemia cells and coagulation activation: a human subject study.
Zhao H; Sun J; Yan L; Jin B; Hou W; Cao F; Li H; Zhou J; Zhang Y
Ann Hematol; 2021 Jun; 100(6):1473-1483. PubMed ID: 33893844
[TBL] [Abstract][Full Text] [Related]
29. Changes in plasma levels of tissue-plasminogen activator/inhibitor complex and active plasminogen activator inhibitor in patients with disseminated intravascular coagulation.
Asakura H; Jokaji H; Saito M; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Matsuda T
Am J Hematol; 1991 Mar; 36(3):176-83. PubMed ID: 1899963
[TBL] [Abstract][Full Text] [Related]
30. Microparticle bearing tissue factor: a link between promyelocytic cells and hypercoagulable state.
Gheldof D; Mullier F; Bailly N; Devalet B; Dogné JM; Chatelain B; Chatelain C
Thromb Res; 2014 Mar; 133(3):433-9. PubMed ID: 24290525
[TBL] [Abstract][Full Text] [Related]
31. Advances in the management of coagulopathy in acute promyelocytic leukemia.
Sanz MA; Montesinos P
Thromb Res; 2020 Jul; 191 Suppl 1():S63-S67. PubMed ID: 32736781
[TBL] [Abstract][Full Text] [Related]
32. Omega-3 fatty acids predict recurrent venous thromboembolism or total mortality in elderly patients with acute venous thromboembolism.
Reiner MF; Stivala S; Limacher A; Bonetti NR; Méan M; Egloff M; Rodondi N; Aujesky D; von Schacky C; Lüscher TF; Camici GG; Beer JH
J Thromb Haemost; 2017 Jan; 15(1):47-56. PubMed ID: 27790827
[TBL] [Abstract][Full Text] [Related]
33. Association between smoking and recurrence of venous thromboembolism and bleeding in elderly patients with past acute venous thromboembolism.
Carruzzo P; Méan M; Limacher A; Aujesky D; Cornuz J; Clair C
Thromb Res; 2016 Feb; 138():74-79. PubMed ID: 26688323
[TBL] [Abstract][Full Text] [Related]
34. Plasma microRNAs as potential biomarkers in diagnosis of acute venous thromboembolism.
Li CT; Jiang X; He XQ; Li DY; Chen SH; Yao SX; Zhang L; Zhao ZR
Clin Hemorheol Microcirc; 2023; 84(4):435-448. PubMed ID: 37334587
[TBL] [Abstract][Full Text] [Related]
35. Impaired plasminogen binding in patients with venous thromboembolism: Association with protein carbonylation.
Siudut J; Natorska J; Zabczyk M; Zajac D; Seweryn K; Rąpała-Kozik M; Undas A
Thromb Res; 2018 Mar; 163():12-18. PubMed ID: 29324332
[TBL] [Abstract][Full Text] [Related]
36. Tissue Factor As a Predictor of Recurrent Venous Thromboembolism in Malignancy: Biomarker Analyses of the CATCH Trial.
Khorana AA; Kamphuisen PW; Meyer G; Bauersachs R; Janas MS; Jarner MF; Lee AY
J Clin Oncol; 2017 Apr; 35(10):1078-1085. PubMed ID: 28029329
[TBL] [Abstract][Full Text] [Related]
37. Trends and outcomes of venous thromboembolism in adult hospitalizations with acute myeloid leukemia: analysis of nationwide inpatient sample from 2010 to 2014.
Khadka S; Solanki D; Singh J; Kichloo A; Patel NR; Sharma P; Chugh S; Solanki S
Postgrad Med; 2021 Mar; 133(2):160-165. PubMed ID: 33305685
[No Abstract] [Full Text] [Related]
38. Coagulopathy in cytogenetically and molecularly distinct acute leukemias at diagnosis: Comprehensive study.
Guo Z; Chen X; Tan Y; Xu Z; Xu L
Blood Cells Mol Dis; 2020 Mar; 81():102393. PubMed ID: 31918382
[TBL] [Abstract][Full Text] [Related]
39. Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival.
Ku GH; White RH; Chew HK; Harvey DJ; Zhou H; Wun T
Blood; 2009 Apr; 113(17):3911-7. PubMed ID: 19088376
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic and Prognostic Value of TAT, PIC, TM, and t-PAIC in Malignant Tumor Patients With Venous Thrombosis.
Zhou K; Zhang J; Zheng ZR; Zhou YZ; Zhou X; Wang LD; Suo B; Jiang XF; Liu PJ; Wang DH
Clin Appl Thromb Hemost; 2020; 26():1076029620971041. PubMed ID: 33141604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
